Curtis L. Triplitt, Pharm.D., CDCES
Many patients on CGM stop use because of common, easily overcome barriers.
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE
Insulin has been available for nearly 100 years. Now that insulin has met technology, diabetes care and management evolve to a whole new level.
Michele L. Matthews, Pharm.D., BCACP, CPE, FASHP
A successful interprofessional pain team depends on responsibility, accountability, cooperation, communication, and mutual trust and respect.
Timothy J. Atkinson, Pharm.D., BCPS, CPE
Take heed of these simple but proven strategies to overcome barriers in improving pain management and promoting safe use of opioids.
Lee A. Kral, Pharm.D., CPE
Long-term adverse effects of opioids are sneaky. Make sure you and your patients don't miss them!
Patricia C. Kienle, M.P.A., FASHP
Let’s dispel some common myths about USP Chapter <797>, which has been a sterile compounding standard since 2004 (revisions in 2008 and 2019).
Eric S. Kastango, B.S.Pharm., M.B.A., FASHP
Since the definition of compounding in revised USP Chapter <797> now excludes reconstitution of drug vials according to the package insert, now more than ever, aseptic technique matters.
Ashley Duty, Pharm.D., M.S.